Please try another search
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company is headquartered in London, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Bruce Edward Keogh | 68 | 2018 | Independent Non-Employee Director |
Donald M. Berwick | 76 | 2018 | Independent Non-Employee Director |
Troyen A. Brennan | 68 | 2016 | Non-Employee Director |
George R. Neble | 66 | 2020 | Independent Co-Chairman of the Board |
Lurene Julia Wong Joseph | 63 | 2016 | Independent Co-Chairman of the Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review